We are grateful for our institutional partners, whose collaboration helps us make an even greater impact for patients and families affected by hairy cell leukemia.
Supporting promising research
Since 2016, we have partnered with the SASS Foundation for Medical Research, Inc. to jointly fund up to $2 million in Hairy Cell Leukemia research grants and fellowship awards through 2021.
Funding new translational research
In 2017, we began a partnership with the SASS Foundation and LLS to jointly support $1.2 million in new HCL translational research over a 3-year period.
strengthening patient education
AstraZeneca has provided financial support to defray costs related to our annual Hairy Cell Leukemia patient seminar and other educational resources.